The brazil mammography market size is expected to grow from USD 49.14 million in 2025 to USD 53.18 million in 2026 and is forecast to reach USD 78.91 million by 2031 at 8.22% CAGR over 2026-2031. This report is Segmented by Product Type (Digital Systems, Analog Systems, Breast Tomosynthesis, Other Product Types), End User (Hospitals, Diagnostic Centers, Others), and Geography (Brazil). The Market Forecasts are Provided in Terms of Value (USD).
Growing AI adoption multiplies the clinical value of digital platforms. Implementations at Beneficência Portuguesa achieved 97% diagnostic accuracy, illustrating how software upgrades leverage installed hardware to lift clinical performance and reimbursement potential. ANVISA’s RDC 611/2022 quality-assurance mandates favor facilities that invest in compliant digital technology, locking in further share gains for the digital segment within the Brazil mammography market.
Brazil Mammography Market Trends and Insights
Growing burden of breast cancer
The annual incidence of 73,610 new female breast cancer cases in 2023 and the notification that 1 in 3 diagnoses occurs in women under 50 are expanding the target cohort for routine imaging. Clinical societies now recommend lowering the SUS screening entry age to 40, potentially enlarging the eligible population by 40%. Higher late-stage detection in SUS-dependent regions is sharpening the political focus on earlier diagnosis, pushing capital spending on imaging infrastructure. Together, these epidemiological and policy forces lift baseline demand across all product classes within the Brazil mammography market.Roll-out of government-funded nationwide screening programs
PAC Saúde 2025 assigns USD 1.8 billion for 180,000 new health-equipment units, earmarking mammography systems for basic clinics in underserved zones. São Paulo’s “Mulheres de Peito” allows women aged 50-69 to self-schedule exams, and its mobile fleet conducted more than 24,000 screenings across 47 towns in 2023. The new oncology navigation rule (Portaria 6,592/2025) mandates rapid routing from suspicion to treatment, indirectly lifting imaging throughput. These central and state programs institutionalize volume and underpin the future base of the Brazil mammography market.Radiologist shortage outside tier-1 metros
Only 15% of board-certified breast imagers practice in the North and Northeast, constraining throughput despite rising equipment availability. Federal incentives totaling USD 86 million under the “Agora Tem Especialistas” program aim to relocate physicians, yet take-up remains slow. The mismatch between technology deployment and specialist distribution tempers capacity expansion and slows adoption curves in remote markets within the Brazil mammography market.Other drivers and restraints analyzed in the detailed report include:
- Rapid private-sector conversion from analog to digital/tomosynthesis
- Reimbursement expansion for 3-D tomosynthesis
- Capital-equipment budget freeze in public hospitals
Segment Analysis
Digital systems controlled 69.58% of the Brazil mammography market in 2025 owing to superior image quality, PACS integration, and lower radiation exposure. The Brazil mammography market size for breast tomosynthesis is expected to expand at a 9.31% CAGR, propelled by false-positive reductions of up to 40% and enhanced lesion visibility in dense breasts. Analog units linger mainly in lower-income municipalities but are slated for replacement under federal équipement grants. Contrast-enhanced mammography and molecular breast imaging occupy nascent, high-margin niches in premium private hospitals.Growing AI adoption multiplies the clinical value of digital platforms. Implementations at Beneficência Portuguesa achieved 97% diagnostic accuracy, illustrating how software upgrades leverage installed hardware to lift clinical performance and reimbursement potential. ANVISA’s RDC 611/2022 quality-assurance mandates favor facilities that invest in compliant digital technology, locking in further share gains for the digital segment within the Brazil mammography market.
Complete Report Scope:
- By Product Type
- Digital Systems
- Analog Systems
- Breast Tomosynthesis
- Other Product Types
- By End User
- Hospitals
- Diagnostic Centers
- Others
List of Companies Covered in this Report:
- Hologic
- GE Healthcare
- Siemens Healthineers
- Fujifilm Holdings Corp.
- Koninklijke Philips
- Canon
- Carestream Health
- Planmed
- Metaltronica
- Neusoft Medical Systems
- Lunit
- IMS Giotto S.p.A.
- Agfa-Gevaert
- Konica Minolta
- Delphinus Medical Technologies
- Volpara Health Technologies
- ScreenPoint Medical B.V.
- Koning
- Trident Medical Imaging
- Mylab Rayx Indústria e Comércio Ltda.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
1 Introduction
4 Market Landscape
5 Market Size & Growth Forecasts
6 Competitive Landscape
7 Market Opportunities & Future Outlook
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Hologic Inc.
- GE HealthCare
- Siemens Healthineers
- Fujifilm Holdings Corp.
- Koninklijke Philips N.V.
- Canon Medical Systems Corp.
- Carestream Health Inc.
- Planmed Oy
- Metaltronica SpA
- Neusoft Medical Systems
- Lunit Inc.
- IMS Giotto S.p.A.
- Agfa-Gevaert Group
- Konica Minolta Inc.
- Delphinus Medical Technologies
- Volpara Health Technologies
- ScreenPoint Medical B.V.
- Koning Corporation
- Trident Medical Imaging
- Mylab Rayx Indústria e Comércio Ltda.
